2006
DOI: 10.1016/j.bios.2006.01.012
|View full text |Cite
|
Sign up to set email alerts
|

Poly(vinylpyrrolidone)-doped nitric oxide-releasing xerogels as glucose biosensor membranes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
26
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
4
3
1

Relationship

3
5

Authors

Journals

citations
Cited by 21 publications
(28 citation statements)
references
References 27 publications
2
26
0
Order By: Relevance
“…Indeed, sensor response effects due to NO release and changes in membrane permeability (water uptake) were shown to significantly decrease during this preconditioning period (data not shown). Response and calibration curves were obtained by injecting 1 M glucose aliquots into 30 mL PBS at room temperature under constant stirring and an applied potential of +0.6 V vs. Ag/AgCl (Schoenfisch et al, 2006; Shin et al, 2004). Permeability ( italicPie) was defined electrochemically as the ratio of peak current at the hybrid sol–gel/polyurethane glucose sensor (Δ I x ) and bare platinum electrode (Δ I b ) response at either 0.79 mM H 2 O 2 ( PH2O2e) or air saturated solution ( PO2e) (Schoenfisch et al, 2006; Shin et al, 2008).…”
Section: Methodsmentioning
confidence: 99%
“…Indeed, sensor response effects due to NO release and changes in membrane permeability (water uptake) were shown to significantly decrease during this preconditioning period (data not shown). Response and calibration curves were obtained by injecting 1 M glucose aliquots into 30 mL PBS at room temperature under constant stirring and an applied potential of +0.6 V vs. Ag/AgCl (Schoenfisch et al, 2006; Shin et al, 2004). Permeability ( italicPie) was defined electrochemically as the ratio of peak current at the hybrid sol–gel/polyurethane glucose sensor (Δ I x ) and bare platinum electrode (Δ I b ) response at either 0.79 mM H 2 O 2 ( PH2O2e) or air saturated solution ( PO2e) (Schoenfisch et al, 2006; Shin et al, 2008).…”
Section: Methodsmentioning
confidence: 99%
“…The range of biomedical applications for NO may necessitate multiple formulations including gaseous NO, low molecular weight molecules, and macromolecular particles, gels and coatings. For example, polymeric device coatings capable of releasing NO in a controlled manner have been shown to decrease bacterial infection and improve tissue integration and/or blood compatibility for subcutaneous glucose sensors, 7, 39 orthopedic devices, 40, 41 and vascular stents. 42 Macromolecular NO release scaffolds are also being developed as stand-alone therapeutics against pathogens 43, 44 and cancer, 10 with much of their efficacy related to their ability to deliver large NO payloads directly to cells.…”
Section: Reporting Nitric Oxide Releasementioning
confidence: 99%
“…3 As such, therapeutics that either regulate NOS activity or produce NO exogenously have become an important research area. Indeed, the number of scaffolds that chemically store and deliver NO include NO-releasing proteins, 4 nanoparticles, 5, 6 and polymers 7, 8 (see Nitric Oxide Release Part I: Macromolecular Scaffolds). These exogenous sources of NO have been investigated as potential medicinal agents for cardiovascular, 2, 9 cancer, 10 antibacterial, 11, 12 and wound healing 11, 13 therapies as discussed in Nitric Oxide Release Part II: Therapeutic Applications.…”
Section: Introductionmentioning
confidence: 99%
“…glucose) 32,33 sensors and biosensors. While the diffusion of NO through these materials was rapid, the intrinsic permeability of O 2 , a highly nonpolar molecule, was quite low.…”
Section: Mn II (No)tpps Formation In Xerogel Filmsmentioning
confidence: 99%